graft versus host disease (GVHD) | Page 8 | Aplastic Anemia & MDS International Foundation Return to top.

graft versus host disease (GVHD)

Trading One Disease for Another: Patients With Chronic Graft-vs-Host Disease May Face Lifelong Complications

The field of allogeneic stem cell transplantation continues to improve survival for patients with previously incurable blood cancers. However, up to 50% of patients who undergo transplantation with donor cells will develop chronic graft-vs-host disease, a potentially deadly condition that can also cause lifelong complications.

James Cook, MD, PhD

MD, PhD Cook, James
Professor of Pathology
Cleveland Clinic, Learner School of Medicine

James R. Cook, M.D., Ph.D., is a Professor of Pathology at the Cleveland Clinic Lerner College of Medicine.  He serves as Section Head of Hematopathology in the Department of Laboratory Medicine.  Dr. Cook's clinical interests focus on diagnostic hematopathology and molecular diagnostics.

Living with GVHD: Diagnosis and Treatment

Melhem Solh, M.D., is board certified in the subspecialties of medical oncology and hematology. Dr. Solh is a Northside Hospital Blood and Marrow Transplant and Leukemia Program physician. In 2019, Dr. Solh was recognized as among Atlanta’s Top Doctors in his specialty by Castle Connolly.

In this webinar, Dr. Melhem Solh from The Blood and Marrow Transplant Group of Georgia will discuss what is GVHD, how it is diagnosed, signs and symptoms, treatment options and how patients can manage the diagnosis.

2021 March for Marrow Texas - VIRTUAL Walk and 5K

Join together virtually with fellow patients, families, caregivers, and friends to raise awareness for

Event Date: 
Fri, 03/26/2021 - 8:00pm (EDT) to Fri, 04/02/2021 - 8:00pm (EDT)
Community Event Type: 
Share with addtoany.com.